Cardiac amyloidosis is a rare disease that significantly impacts quality of life. Recent advances in imaging technology and more thorough genetic analyses have revealed it may be more common than previously believed, but new pharmacotherapies have emerged that directly modify disease progression and improve patient outcomes.

This course will help clinicians better recognize the signs and symptoms, interpret diagnostic findings, evaluate emerging treatment options, and establish referral to accelerate treatment for patients with cardiac amyloidosis.

	Certified Patient Cases Test your knowledge and sharpen your diagnostic skills to recognize these life-threatening conditions earlier and bring appropriate treatment to your patients sooner. Case 1: A Thickened Heart Re-Imagined Case 2: The Imaging Approach to Suspected Cardiac Amyloidosis: Don’t Forget about the Plasma Cell Case 3: A Comprehensive Approach to the Evaluation and Treatment of Transthyretin Amyloidosis (ATTR)
	Self-Paced Learning Dive into this engaging eLearning curriculum to increase recognition and detection of cardiac amyloidosis to accelerate diagnosis and treatment. Treatment Options and Referral in Cardiac Amyloidosis A Suspicious Mind: Signs, Symptoms, and Diagnosis of Cardiac Amyloidosis
	Webinar Join expert faculty Farooq Sheikh, MD, FACC and Frederick L Ruberg, MD, FACC in this session to forge a new path to detect and diagnose cardiomyopathies and accelerate treatment to improve patient outcomes. Meeting On Demand

Click here to see additional Spotlight Topics in the Clinical Spotlight Series